NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Peripheral Neuropathy


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Alnylam Provides Update on RNAi Pipeline, Platform, and Technology at Its R&D Day
2009 NOV 23 ... a marked and nearly complete reduction of mutant TTR protein accumulation by over 95% in peripheral tissues affected by disease. Specifically, ALN-TTR was found to block mutant TTR ... esophagus, and stomach - tissues that are associated with the sensory and autonomic neuropathy and the severe gastrointestinal dysfunction observed in patients with ATTR. The ...
Subject: Alnylam Pharmaceuticals, Inc.
Price: $3.00
*
Data on drug delivery detailed by researchers at Emory University
2009 NOV 16 ... of application to degenerative disorders of the nervous system, including nerve injury, peripheral neuropathy, and amyotrophic lateral sclerosis." Federici and colleagues published ...
Subject: Drug Delivery
Price: $3.00
*
Findings from Royal Perth Hospital in clinical biochemistry reported
2009 NOV 24 ... for OGTT identified included polycystic ovary syndrome or metabolic syndrome (8%), peripheral neuropathy (3%) and as part of a research protocol (12%). Forty-two (35%) were inpatients at the ...
Subject: Clinical Biochemistry
Price: $3.00
*
Findings in medicare and medicaid reported from J.M. Margolis and co-researchers
2009 NOV 16 ... (PA) policy restricting access to pregabalin for the management of diabetic peripheral neuropathy (DPN) or postherpetic neuralgia (PHN) on the overall utilization of pharmacologic ...
Subject: Medicare and Medicaid
Price: $3.00
*
New behavior research reported from Loyola University
2009 NOV 16 ... study in Molecular Pain (Increased chemokine signaling in a model of HIV1-associated peripheral neuropathy. Molecular Pain, 2009;5():48). Additional information can be obtained by ...
Subject: Behavior
Price: $3.00
*
November/December 2009 Annals of Family Medicine tip sheet
2009 NOV 29 ... Kan.Lack of Evidence to Support the Use of Microfilament Testing to Diagnose Peripheral Neuropathy A systematic review by Dros et al evaluates monofilament testing for diagnosis of...
Subject: American Academy of Family Physicians
Price: $3.00
*
PanGenetics Announces Acquisition by Abbott of PG110 anti-NGF Antibody to Treat Chronic Pain
2009 NOV 23 ... which interaction plays a key role in pain transduction mechanisms in the adult peripheral nervous system. PG110 does not cross-react with other neurotrophins and therefore is a ... COX-2 Inhibitors, Cancer, Chronic Pain, Clinical Trial Research, Diabetes, Diabetic Neuropathy, Diagnostics, Drug Development, Endocrinology, Genetics, Humanized Antibodies, ...
Subject: PanGenetics
Price: $3.00
*
Proper Foot Care Can Help Decrease Risk of Foot Ulcers & Amputations for Diabetics
2009 NOV 23 ... risk of foot amputations. "Diabetics, especially those with significant peripheral neuropathy, are less likely to walk for exercise and would therefore have a higher risk for blood ...
Subject: Ulcer
Price: $3.00
*
Recent findings in polyneuropathies described by researchers from Cheju National University
2009 NOV 23 ... nervous impairments such as polyneuropathy are less clear." "Recently, peripheral neuropathy was proposed as one of the CADASIL phenotypes. We investigated peripheral nerve ...
Subject: Polyneuropathies
Price: $3.00
*
Reports from S.K. Fokter and co-researchers add new data to research in arthroplasty
2009 NOV 23 ... showed substantial liner wear. MRI of the lumbar spine was unrevealing and EMG showed a peripheral neurogenic process involving the left femoral nerve. The large intrapelvic cystic mass ... their study in Clinical Orthopaedics and Related Research (Case Report: Femoral Neuropathy Secondary to Total Hip Arthroplasty Wear Debris. Clinical Orthopaedics and Related ...
Subject: Arthroplasty
Price: $3.00
*
Research conducted by S. Ramchandren and co-researchers has updated our knowledge about neuropathy
2009 NOV 23 ... "of review The management of peripheral neuropathy associated with monoclonal gammopathies has been advanced by recent clinical studies. We ...
Subject: Neuropathy
Price: $3.00
*
Research on neuropathy published by D.S. Douglas et al
2009 NOV 23 ... "Peripheral neuropathy is a broad category of disorders with a diverse etiology, grouped together by their ...
Subject: Neuropathy
Price: $3.00
*
Researchers from National Hospital Organization detail findings in neuropathy
2009 NOV 23 ... "of review This review discusses the literature on peripheral neuropathy caused by medication-induced toxicity or immunological mechanism with special attention ...
Subject: Neuropathy
Price: $3.00
*
Studies from Aarhus University yield new data on neuropathic pain
2009 NOV 23 ... phenytoin is still unsettled. A recent trial has found an effect of cannabinoids also in peripheral neuropathic pain. Various topical treatments such as topical lidocaine, topically ... serotonin noradrenaline reuptake inhibitors have been found to reduce pain in painful neuropathy. The new anticonvulsant lacosamide may have some effect in painful polyneuropathy, ...
Subject: Neuropathic Pain
Price: $3.00
*
Studies from University of Sao Paulo in the area of brachial plexus injury described
2009 NOV 16 ... additional information, contact R.S. Martins, University of Sao Paulo, School Medical, Peripheral Nerve Surgery Unit, Sao Paulo, Brazil. The publisher of the journal ... USA. Keywords: Brazil, Sao Paulo, Brachial Plexus Injury, Brachial Plexus Neuropathy, Electromyography, Neonatology, Neurology, Neuroma, Neurosurgery, University of Sao ...
Subject: Brachial Plexus Injury
Price: $3.00
*
U-M Researchers Receive $1.8 Million Grant to Develop New Therapy for Neuropathic Pain
2009 NOV 23 ... promise not only for the treatment of pain but also ultimately for the treatment of peripheral neuropathy itself. Fink has received research funding from Diamyd related to the human ...
Subject: Herpes Simplex
Price: $3.00
*
ZIOPHARM Presents Positive Palifosfamide Sarcoma Randomized Phase II Interim Data at Annual Meeting of the Connective Tissue Oncology Society
2009 NOV 23 ... results from the trial with IV-administered darinaparsin in lymphoma, particularly peripheral T-cell lymphoma ("PTCL"), were reported at the American Society of Clinical Oncology ... benefits, including oral dosing, application in multi-drug resistant tumors, no neuropathy and minimal overall toxicity. In multiple Phase I trials in cancer patients, oral ...
Subject: ZIOPHARM Oncology, Inc.
Price: $3.00
*
ZIOPHARM Reports Third Quarter Financial Results and Updated Clinical Progress
2009 NOV 23 ... ZIO-101) study results in lymphoma with the intent of conducting a registration trial in peripheral T-cell lymphoma, also as early as the first half of 2010. The oral darinaparsin Phase I ... benefits, including oral dosing, application in multi-drug resistant tumors, no neuropathy and minimal overall toxicity. In multiple Phase I trials in cancer patients, oral ...
Subject: ZIOPHARM Oncology, Inc.
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login